{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:21:01Z","timestamp":1771928461089,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Although circumferential pulmonary vein isolation (CPVI) is the standard treatment for persistent nonvalvular atrial fibrillation (PeNVAF), its efficacy remains limited. Combining CPVI with linear ablation and ethanol infusion into the vein of Marshall (EI-VOM) (CPVI\u2009+\u2009PLUS) may improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This single-center retrospective study included hospitalized patients with PeNVAF who underwent their first radiofrequency ablation at Zigong First People's Hospital from August 2022 to August 2024. After propensity score matching (PSM), 132 patients were assigned to each group: the CPVI\u2009+\u2009PLUS group (combined EI-VOM and linear ablation) and the CPVI-only group. Outcomes were assessed at 3 and 6 months, including AF recurrence, complications, and cardiac function. Quality of life was evaluated at 6 months using the Atrial Fibrillation Effect on Quality-of-Life Questionnaire (AFEQT). The primary endpoints were AF recurrence rate and arrhythmia-free survival at 6 months after ablation; secondary endpoints included changes in cardiac function parameters, quality-of-life scores, and complication rates. Kaplan\u2013Meier analysis was used to compare arrhythmia-free survival between the two groups, and univariate and multivariate logistic regression analyses were performed to identify risk factors for AF recurrence. In addition, a stacking ensemble model was developed to enhance prediction of AF recurrence after ablation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were no significant differences in baseline demographics, comorbidities, laboratory, or echocardiographic parameters between the two groups. The CPVI\u2009+\u2009PLUS group had a longer procedure time than the CPVI group, but intraoperative complication rates were similar. At 6-month follow-up, the CPVI\u2009+\u2009PLUS group showed significantly better AFEQT, left ventricular ejection fraction (LVEF), left atrial diameter(LAD), and left ventricular end-diastolic diameter (LVEDD) compared to the CPVI group. Recurrence rates of AF were lower in the CPVI\u2009+\u2009PLUS group, and arrhythmia-free survival time was longer. Multivariate analysis identified coronary artery disease, heart failure, severe preoperative valvular regurgitation, intraoperative myocardial injury, longer AF course, and larger LAD as independent risk factors for recurrence. Additional ablation strategies and left atrial appendage occlusion were protective factors. The stacking ensemble model achieved high accuracy, precision, recall, F1 score, and ROC-AUC in both training and validation cohorts. Feature importance analysis consistently identified AF course, age, body mass index, B-type natriuretic peptide, LVEF, platelet count, and uric acid as core predictors of recurrence risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CPVI\u2009+\u2009PLUS significantly improved arrhythmia-free survival, cardiac function, and quality of life in patients with PeNVAF without increasing procedural risk. Multivariate and machine learning analyses confirmed that additional ablation and left atrial appendage occlusion were protective against recurrence, while heart failure, valvular regurgitation, and longer AF course increased risk. The stacking model showed excellent predictive performance, and key features identified may support precise risk stratification and individualized therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1689942","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:16:48Z","timestamp":1770034608000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective cohort and machine learning study on the efficacy, safety, and recurrence prediction of combined EI-VOM and linear ablation in persistent Non-valvular atrial fibrillation"],"prefix":"10.3389","volume":"13","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Health Humanities Research Center, Sichuan Vocational College of Health and Rehabilitation","place":["Zigong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jinniu District People\u2019s Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhai","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First People\u2019s Hospital of Zigong City","place":["Zigong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"04154","DOI":"10.7189\/jogh.13.04154","article-title":"Global, regional, and national burdens of atrial fibrillation\/flutter from 1990 to 2019: an age-period-cohort analysis using the global burden of disease 2019 study","volume":"13","author":"Li","year":"2023","journal-title":"J Glob Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100439","DOI":"10.1016\/j.lanwpc.2022.100439","article-title":"Prevalence and risk of atrial fibrillation in China: a national cross-sectional epidemiological study","volume":"23","author":"Shi","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"B3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1161\/CIRCULATIONAHA.110.946806","article-title":"Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up","volume":"122","author":"Ouyang","year":"2010","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0022-5223(19)36684-X","article-title":"The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure","volume":"101","author":"Cox","year":"1991","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1056\/NEJMoa1408288","article-title":"Approaches to catheter ablation for persistent atrial fibrillation","volume":"372","author":"Verma","year":"2015","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/europace\/euv407","article-title":"Mitral isthmus ablation: the importance of epicardial connections between the coronary sinus and Marshall bundle","volume":"18","author":"Hayashi","year":"2016","journal-title":"Europace"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jacep.2020.06.025","article-title":"Electrical isolation of the Marshall bundle by radiofrequency catheter ablation: in patients with atrial fibrillation","volume":"6","author":"Kashimura","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1161\/CIRCEP.108.818427","article-title":"Retrograde ethanol infusion in the vein of Marshall: regional left atrial ablation, vagal denervation and feasibility in humans","volume":"2","author":"Valderrabano","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/HCO.0000000000000183","article-title":"Ethanol for the treatment of cardiac arrhythmias","volume":"30","author":"Schurmann","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1001\/jama.2020.16195","article-title":"Effect of catheter ablation with vein of marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: the VENUS randomized clinical trial","volume":"324","author":"Valderrabano","year":"2020","journal-title":"JAMA"},{"key":"B12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.26599\/1671-5411.2024.03.009","article-title":"Chinese Society of cardiology CMA, heart rhythm committee of Chinese society of biomedical E. Chinese guidelines for the diagnosis and management of atrial fibrillation","volume":"21","author":"Ma","year":"2024","journal-title":"J Geriatr Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","article-title":"Development and validation of the atrial fibrillation effect on QualiTy-of-life (AFEQT) questionnaire in patients with atrial fibrillation","volume":"4","author":"Spertus","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/jce.15573","article-title":"Distribution of atrial low voltage induced by vein of Marshall ethanol infusion","volume":"33","author":"Kamakura","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/jcdd9080270","article-title":"Ethanol infusion of vein of marshall for the treatment of persistent atrial fibrillation: the basics and clinical practice","volume":"9","author":"He","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.hrthm.2012.03.008","article-title":"Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablation","volume":"9","author":"Baez-Escudero","year":"2012","journal-title":"Heart Rhythm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/pace.14052","article-title":"Ethanol infusion into the vein of Marshall for recurrent perimitral atrial tachycardia after catheter ablation for persistent atrial fibrillation","volume":"44","author":"Sang","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jacep.2021.06.019","article-title":"Durability of left atrial lesions after ethanol infusion in the vein of Marshall","volume":"8","author":"Laredo","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jacep.2021.09.020","article-title":"Optimized computed tomography acquisition protocol for ethanol infusion into the vein of Marshall","volume":"8","author":"Takagi","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/jce.16491","article-title":"Left atrial structure and function following ethanol infusion into vein of marshall (MR-SHALL study)","volume":"36","author":"Aranyo","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"euae265","DOI":"10.1093\/europace\/euae265","article-title":"Comparative effects of different power settings for achieving transmural isolation of the left atrial posterior wall with radiofrequency energy","volume":"26","author":"La Fazia","year":"2024","journal-title":"Europace"},{"key":"B23","doi-asserted-by":"publisher","first-page":"20200492","DOI":"10.4022\/jafib.20200492","article-title":"Adjunctive vein of Marshall ethanol infusion during atrial fibrillation ablation: a systematic review and meta-analysis","volume":"14","author":"Mhanna","year":"2021","journal-title":"J Atr Fibrillation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e26513","DOI":"10.1097\/MD.0000000000026513","article-title":"Formula to estimate left atrial volume using antero-posterior diameter in patients with catheter ablation of atrial fibrillation","volume":"100","author":"Sangsriwong","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4556671","DOI":"10.1155\/2022\/4556671","article-title":"Markers of inflammation, oxidative stress, and fibrosis in patients with atrial fibrillation","volume":"2022","author":"Pauklin","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1111\/jcmm.16350","article-title":"Left atrial fibrosis in atrial fibrillation: mechanisms, clinical evaluation and management","volume":"25","author":"Ma","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2021.12.029","article-title":"Restoring Sinus rhythm reverses cardiac remodeling and reduces valvular regurgitation in patients with atrial fibrillation","volume":"79","author":"Soulat-Dufour","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e009317","DOI":"10.1161\/CIRCIMAGING.119.009317","article-title":"Reverse remodeling of the mitral valve Complex after radiofrequency catheter ablation for atrial fibrillation: a serial 3-dimensional echocardiographic study","volume":"12","author":"Nishino","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.3390\/jcm12155034","article-title":"The relationship between hyperuricemia and echocardiographic parameters in patients with chronic atrial fibrillation","volume":"12","author":"Jordhani","year":"2023","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00380-022-02108-w","article-title":"Declines in serum uric acid level after catheter ablation of atrial fibrillation","volume":"37","author":"Aoyama","year":"2022","journal-title":"Heart Vessels"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1093\/eurheartj\/ehz154","article-title":"Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of medicare claims data","volume":"40","author":"Singh","year":"2019","journal-title":"Eur Heart J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10557-022-07315-1","article-title":"Sacubitril\/valsartan can reduce atrial fibrillation recurrence after catheter ablation in patients with persistent atrial fibrillation","volume":"37","author":"Wang","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","article-title":"Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study","volume":"15","author":"Cresti","year":"2019","journal-title":"EuroIntervention"},{"key":"B34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10840-019-00696-8","article-title":"The impact of catheter ablation of atrial fibrillation on the left atrial volume and function: study using three-dimensional echocardiography","volume":"57","author":"Hwang","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"666465","DOI":"10.3389\/fcvm.2021.666465","article-title":"Effect of left atrial appendage closure in combination with catheter ablation on left atrial function for persistent atrial fibrillation","volume":"8","author":"Yang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10840-019-00674-0","article-title":"Impact of left atrial appendage occlusion on left atrial function-the LAFIT watchman study","volume":"58","author":"Murtaza","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.hrthm.2017.01.042","article-title":"Percutaneous left atrial appendage closure improves left atrial mechanical function through frank-starling mechanism","volume":"14","author":"Coisne","year":"2017","journal-title":"Heart Rhythm"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/europace\/euv070","article-title":"Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation","volume":"17","author":"Calvo","year":"2015","journal-title":"Europace"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/europace\/euw007","article-title":"Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation","volume":"18","author":"Fassini","year":"2016","journal-title":"Europace"},{"key":"B40","doi-asserted-by":"publisher","first-page":"813914","DOI":"10.3389\/fcvm.2022.813914","article-title":"Machine learning-predicted progression to permanent atrial fibrillation after catheter ablation","volume":"9","author":"Park","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.hrthm.2024.07.110","article-title":"Catheter ablation for atrial fibrillation in patients with significant mitral regurgitation: a systematic review and meta-analysis","volume":"22","author":"Okazaki","year":"2025","journal-title":"Heart Rhythm"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/PRS.0b013e3181f44abc","article-title":"Observational studies: cohort and case-control studies","volume":"126","author":"Song","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.5662\/wjm.v13.i5.373","article-title":"Challenges and limitations of synthetic minority oversampling techniques in machine learning","volume":"13","author":"Alkhawaldeh","year":"2023","journal-title":"World J Methodol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1689942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:29:45Z","timestamp":1771925385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1689942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":44,"alternative-id":["10.3389\/fcvm.2026.1689942"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1689942","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"article-number":"1689942"}}